With a dedicated product theater and new real-world evidence posters, Theranica will spotlight how the Nerivio® REN wearable is reshaping...
Groundbreaking remotely operable robotic system to transform intervention for stroke and cardiovascular disease, while radically expanding access to care for...
ATLANTA, Oct. 6, 2025 /PRNewswire/ -- In recognition of Sudden Cardiac Arrest Awareness Month, CENTEGIX is partnering with the Sudden...
Revolutionary technology empowers parents with advanced insights about their children's development, transforming reactive pediatric care into proactive health monitoring WINNIPEG,...
Clario partners with the University of Oxford's NeuroMetrology Lab to transform Parkinson's disease research with the Opal® wearable sensor system. Partnership...
NEW YORK, Oct. 06, 2025 (GLOBE NEWSWIRE) -- LB Pharmaceuticals Inc (“LB Pharmaceuticals” or the “Company”) (Nasdaq: LBRX) today announced...
Successful meeting with FDA enables advancement into pivotal development with Privosegtor in Acute Optic Neuritis (AON) and Non-arteritic Anterior Ischemic...
BELLEVUE, Wash.--(BUSINESS WIRE)--Symetra Life Insurance Company announced that its acquisition through reinsurance of Dearborn Group’s life and disability (LAD) business...
CAMBRIDGE, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company...
First and Only REN-Based Migraine Treatment Approved in China BEIJING and NETANYA, Israel, Sept. 29, 2025 /PRNewswire/ -- Pier 88 Health, a...
VANCOUVER, BC, Sept. 29, 2025 /CNW/ - Beautifi, Canada's leading medical financing provider, is proud to announce the launch of...
Insurtech acquisition unites next-gen AI-powered case design with proven compliance and operational infrastructure NEW YORK, Sept. 29, 2025 /PRNewswire/ --...
The addition of cardiology and neurology experts helps health companies scale evidence-based health products with confidence AUSTIN, Texas, Sept. 25,...
Late-breaking clinical data presented at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis Across non-active...
Seeking an indication for gait and balance deficit in patients with chronic symptoms of stroke under its Breakthrough Device DesignationNEWTOWN,...
A significant, dose-dependent reduction in bone marrow lesion presence and area was observed for LEVI-04 compared with placebo in patients...
Small-group EDI integration breaks market norms bringing automation and accuracy to ancillary benefits administration for groups of any size. INDIANAPOLIS, Sept....
VIENNA, Va., Sept. 24, 2025 /PRNewswire/ -- The National Academy of Elder Law Attorneys (NAELA) and the Special Needs Alliance...
During year 6 of continuous treatment with BRIUMVI the annualized relapse rate was 0.012, equivalent to one relapse occurring every...
KYV-101 IIT data demonstrate promising clinical activity, including robust CAR T penetration into the central nervous system (CNS) and improved...